Biotech Therapeutics
Innovative biotechnology-based therapies covering key therapeutic modalities, including small molecules, antibody therapeutics, gene and cell therapies, and next-generation vaccine technologies.
Executive Search for Drug Discovery & Development Companies
ExecMind partners with biotechnology companies developing therapeutic products to bring executive, scientific, and clinical leaders who translate biological innovation into successful development programs and approved medicines.
Biotech therapeutics organizations operate at the forefront of medical innovation, advancing novel biological modalities, complex development pathways, and high scientific risk. ExecMind supports these companies by identifying leaders capable of integrating discovery science, translational research, clinical development, regulatory strategy, and commercialization planning.
We work with biotech therapeutics companies across Europe at different stages of maturity, from early research-driven organizations to late-stage and commercial biotech companies.
Therapeutic Modalities We Support
- Small-Molecule and Targeted Therapies
- Antibody-Based Therapeutics
- Gene and Cell Therapies
- Next-Generation Vaccine Technologies
- RNA- and Protein-Based Therapeutic Platforms
Leadership Areas We Cover
- Executive & Board-Level Leadership
CEOs, Chief Scientific Officers (CSO), Chief Medical Officers (CMO), R&D leaders, and Board Members shaping strategy and pipeline direction. - Research, Translational & Clinical Development Leadership
Heads of Discovery, Translational Medicine, Clinical Development, and Clinical Operations.
- CMC, Manufacturing & Technical Leadership
Leaders responsible for CMC strategy, technology transfer, external manufacturing oversight, and CDMO partnerships. - Regulatory, Quality & Market Access Leadership
Senior leaders overseeing regulatory affairs, quality systems, pharmacovigilance, and market access strategy.
- Business Development & Strategic Partnerships
Executives leading licensing, partnering, alliances, and corporate development activities.
